NO20014805D0 - Blandinger og fremgangsmåter for behandling og diagnose av brystkreft - Google Patents

Blandinger og fremgangsmåter for behandling og diagnose av brystkreft

Info

Publication number
NO20014805D0
NO20014805D0 NO20014805A NO20014805A NO20014805D0 NO 20014805 D0 NO20014805 D0 NO 20014805D0 NO 20014805 A NO20014805 A NO 20014805A NO 20014805 A NO20014805 A NO 20014805A NO 20014805 D0 NO20014805 D0 NO 20014805D0
Authority
NO
Norway
Prior art keywords
mixtures
treating
methods
breast cancer
diagnosing breast
Prior art date
Application number
NO20014805A
Other languages
English (en)
Other versions
NO20014805L (no
Inventor
Tony N Frudakis
John M Smith
Steven G Reed
Lynda E Misher
Marc W Retter
Davin C Dillon
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20014805D0 publication Critical patent/NO20014805D0/no
Publication of NO20014805L publication Critical patent/NO20014805L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20014805A 1999-04-09 2001-10-03 Blandinger og fremgangsmater for behandling og diagnose av brystkreft NO20014805L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US2000/009312 WO2000061753A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (2)

Publication Number Publication Date
NO20014805D0 true NO20014805D0 (no) 2001-10-03
NO20014805L NO20014805L (no) 2001-12-06

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014805A NO20014805L (no) 1999-04-09 2001-10-03 Blandinger og fremgangsmater for behandling og diagnose av brystkreft

Country Status (15)

Country Link
EP (1) EP1169444A2 (no)
JP (1) JP2002541803A (no)
KR (1) KR20020026418A (no)
CN (1) CN1352683A (no)
AU (1) AU774824B2 (no)
BR (1) BR0009573A (no)
CA (1) CA2365909A1 (no)
CZ (1) CZ20013575A3 (no)
HU (1) HUP0200825A2 (no)
IL (1) IL145719A0 (no)
MX (1) MXPA01010186A (no)
NO (1) NO20014805L (no)
NZ (1) NZ514646A (no)
PL (1) PL350863A1 (no)
WO (1) WO2000061753A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
JP2001501447A (ja) * 1996-01-11 2001-02-06 コリクサ コーポレイション 乳癌の処置および診断のための組成物および方法
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
AU758004B2 (en) * 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
TR200100916T2 (no) * 1998-07-14 2002-06-21 Corixa@@Corporation

Also Published As

Publication number Publication date
AU4213000A (en) 2000-11-14
CA2365909A1 (en) 2000-10-19
IL145719A0 (en) 2002-07-25
WO2000061753A3 (en) 2001-06-28
NZ514646A (en) 2005-04-29
EP1169444A2 (en) 2002-01-09
PL350863A1 (en) 2003-02-10
NO20014805L (no) 2001-12-06
AU774824B2 (en) 2004-07-08
CZ20013575A3 (cs) 2002-10-16
MXPA01010186A (es) 2004-08-12
WO2000061753A2 (en) 2000-10-19
HUP0200825A2 (en) 2002-07-29
KR20020026418A (ko) 2002-04-10
JP2002541803A (ja) 2002-12-10
BR0009573A (pt) 2002-04-16
CN1352683A (zh) 2002-06-05

Similar Documents

Publication Publication Date Title
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO20030714D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20024972D0 (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft
NO20010196L (no) Sammensetninger og fremgangsmÕter for terapi og diagnose av prostatakreft
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
ITMI990375A1 (it) Trattamento del cancro co epotiloni
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
FI20011879A (fi) Röntgentomografiamenetelmä ja -laite
NO20022592L (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
EP1105528A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING BREAST CANCER, DETERMINING THE STAGE AND IMAGING AND TREATING IT
NO996253L (no) Diagnostiske midler og legemidler for maligne tumorer
DK1091D0 (da) Immunkonjugater til diagnose og behandling af cancer
FI990559A (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
EP1175616A4 (en) METHODS FOR DIAGNOSING AND TREATING METASTATIC PROSTATE TUMORS
LU90157B1 (fr) Méthodes de prévention du cancer du sein
NO20014804D0 (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
NO20014805L (no) Blandinger og fremgangsmater for behandling og diagnose av brystkreft
EP1267934A4 (en) NEW METHOD OF DIAGNOSIS, MONITORING, STATUS ASSESSMENT, IMAGE AND TREATMENT OF BREAST CANCER
NO20025594D0 (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
IDP000008233A (id) Metode pencegahan kanker payudara

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application